Type | Private | |
Founded | 2012 | |
HQ | San Jose, CA, US | Map |
Website | ranitherapeutics.com |
Cybersecurity rating | B | More |
Founding Date | 2012 |
Rani Therapeutics total Funding | $176.5 m |
Rani Therapeutics latest funding size | $69 m |
Time since last funding | 3 months ago |
Rani Therapeutics investors | Novartis, InCube Ventures, AstraZeneca, Shire, Western Life Sciences Venture Fund LP, VentureHealth, The Stevanato Group, Crystal Horizon Investments, Pinemount Investment, Pacific Venture Opportunity Fund, GV, Ping An Ventures, Buttonwood Capital, Virtus Inspire Ventures, Cathay Venture, GeneScience Pharmaceuticals, Bossa Ventures, Takeda |
When was Rani Therapeutics founded?
Rani Therapeutics was founded in 2012.
Who are Rani Therapeutics key executives?
Rani Therapeutics's key executives are Mir Imran, Mir Hashim and Svai Sanford.
Who are Rani Therapeutics competitors?
Competitors of Rani Therapeutics include Principia BioPharma, Oramed Pharmaceuticals and Athersys.
Where is Rani Therapeutics headquarters?
Rani Therapeutics headquarters is located at 2051 Ringwood Ave, San Jose.
Where are Rani Therapeutics offices?
Rani Therapeutics has an office in San Jose.
How many offices does Rani Therapeutics have?
Rani Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies